PBLS
PBLS
US6989551014
Parabilis Medicines, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
3.39B EUR
3.38B EUR
Enterprise Value
2.4B EUR
2.34B EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-12.57x
--
Price to Sales
22,937.12x
22,842.83x
Price to Book
3.24x
3.23x
EV/Revenue
16,195.03x
15,818.86x
EV/EBITDA
-14.17x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-3.52%
ende